- Phase 3 trial of first generation protease inhibitor therapy for hepatitis c virus/human immunodeficiency virus coinfection. World Journal of Hepatology. 2017 Academic Article GET IT
Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239.
Journal of Acquired Immune Deficiency Syndromes.
Times cited: 2
A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206.
Times cited: 45
Pilot study of low-dose interleukin-2, pegylated interferon-α2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection.
Journal of Infectious Diseases.
Times cited: 14